Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

Mees lines and Beau lines after chemotherapy

Tzu-Chuan Huang and Tsu-Yi Chao
CMAJ February 23, 2010 182 (3) E149; DOI: https://doi.org/10.1503/cmaj.090501
Tzu-Chuan Huang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tsu-Yi Chao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

A single transverse white band appeared on each of the fingernails of a 27-year-old woman after she received induction chemotherapy with daunorubicin and cytarabine for acute myeloid leukemia. We identified the bands, which did not fade with digital compression, as Mees lines (Figure 1A). In another woman, aged 41 years, fine, transverse depressed lines that were parallel and evenly spaced (Beau lines) developed on all of her fingernails while receiving triweekly docetaxel for metastatic breast cancer (Figure 1B).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1: (A) Mees lines (arrows) in the fingernails of a 27-year-old woman. (B) Beau lines (arrowheads) in the fingernails of a 41-year-old woman.

Transverse linear lesions in nails can result from interruption in the growth of the nail matrix or changes in the colour in the nail itself 1 and may suggest an underlying systemic illness or the effect of toxins. 1–3 Changes in the nails are common in patients receiving chemotherapy, occurring in up to 44% of patients receiving taxanes. 4 In a patient with no history of significant drug-related insult, such lesions may be important clues in the diagnosis of systemic illness.

Changes in the nails that are related to interruption of mitotic activity of the proximal nail matrix include Beau lines and onychomadesis. Beau lines appear as transverse depressions in the nail plates. The depth of the depression represents the extent of damage. The duration of the insult may be estimated by the longitudinal width of the damage; normal nail growth is about 1 mm every six to ten days. 1–3 Onychomadesis results from complete toxicity of the matrix 2 and can present with shedding of the nail or a sulcus that splits the nail plate into two parts. 2,3 This condition is an extreme expression of Beau lines. 3 Beau lines and onychomadesis may be caused by infection, surgery, trauma, Raynaud disease, pemphigus or chemotherapy (i.e., taxoids). 1–3

In Mees lines (i.e., true leukonychia) a change occurs in the colour of the nail with no palpable ridges. 1 Transverse, non-blanching white bands appear that run parallel to the lunula across the entire nail bed. 1 The bands are caused by an insult to the distal nail matrix that does not lead to cessation in growth of the matrix, but instead causes parakeratosis of the ventral nail plate. 2 Mees lines may be confused with Muehrcke lines (i.e., apparent leukonychia), which are paired white lines caused by vascular congestion in the nail bed. 2 Muehrcke lines are easily distinguished from Mees lines because Muehrcke lines fade with digital compression and do not migrate with the growth of the nail. 1–3 Mees lines are associated with arsenic poisoning, Hodgkin lymphoma, carcinoid tumours and chemotherapy (i.e., cyclophosphamide, vincristine and doxorubicin). Muehrcke lines result from liver disease, nephrotic syndrome, malnutrition and severe hypoalbuminemia (less than 20 g/L). 1–3

Footnotes

  • This article has been peer reviewed.

    Competing interests: None declared.

REFERENCES

  1. 1.↵
    Fawcett RS, Linford S, Stulberg DL. Nail abnormalities: clues to systemic disease. Am Fam Physician 2004;69:1417–24.
    OpenUrlPubMed
  2. 2.↵
    Hinds G, Thomas VD. Malignancy and cancer treatment-related hair and nail change. Dermatol Clin 2008;26:59–68.
    OpenUrlCrossRefPubMed
  3. 3.↵
    Piraccini BM, Iorizzo M. Drug reactions affecting the nail unit: diagnosis and management. Dermatol Clin 2007;25:215–21.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Minisini AM, Tosti A, Sobrero AF, et al. Taxanes-induced nail changes: incidence, clinical presentation and outcome. Ann Oncol 2003;14:333–7.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 182 (3)
CMAJ
Vol. 182, Issue 3
23 Feb 2010
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Mees lines and Beau lines after chemotherapy
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Mees lines and Beau lines after chemotherapy
Tzu-Chuan Huang, Tsu-Yi Chao
CMAJ Feb 2010, 182 (3) E149; DOI: 10.1503/cmaj.090501

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Mees lines and Beau lines after chemotherapy
Tzu-Chuan Huang, Tsu-Yi Chao
CMAJ Feb 2010, 182 (3) E149; DOI: 10.1503/cmaj.090501
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Mees lines in high altitude mountaineering
  • Muehrcke lines
  • Google Scholar

More in this TOC Section

  • Penicillin allergy delabelling of patients at risk of sexually transmitted infections in primary care
  • Phthiriasis palpebrarum
  • Penicillin allergy delabelling in pregnancy
Show more Practice

Similar Articles

Collections

  • Article Types
    • Clinical Images
  • Topics
    • Dermatology

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire